A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples-Reference-Cited by-同舟云学术

A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples

Published:2007-03 Issue:1 Volume:9 Page:E60-E83
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Bauer Robert J.,Guzy Serge,Ng Chee

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/aapsj0901007.pdf

Reference47 articles.

1. Csajka C, Verotta D. Pharmacokinetic-pharmacodynamic modelling: history and perspectives.J Pharmacokinet Pharmacodyn. 2006;33:227–279.

2. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.J Pharmacokinet Biopharm. 1980;8:553–571.

3. Pillai G, Mentre F, Steimer JL. Non-linear mixed effects modeling—from methodology and software development to driving implementation in drug development science.J Pharmacokinet Pharmacodyn. 2005;32:161–183.

4. mandema JW. Population pharmacokinetics and pharmacodynamics. In: Welling PG, Tse FLS, eds.Pharmacokinetics. vol. 67. 2nd ed. New York, NY: Marcel Dekker, Inc.; 1995:411–450.

5. Roe DJ. Comparison of population pharmacokinetic modeling methods using simulated data: results from the population modeling workgroup.Stat Med. 1997;16:1241–1262.

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enabling Population Protein Dynamics Through Bayesian Modeling;Bioinformatics;2024-07-30

2. Safety, Pharmacokinetics, and Pharmacodynamics of the New Aldose Reductase Inhibitor Govorestat (AT‐007) After a Single and Multiple Doses in Participants in a Phase 1/2 Study;The Journal of Clinical Pharmacology;2024-07-10

3. Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens;Frontiers in Pharmacology;2024-05-02

4. Population pharmacokinetic rationale for intravenous contezolid acefosamil followed by oral contezolid dosage regimens;Antimicrobial Agents and Chemotherapy;2024-04-03

5. Model-based learn and confirm: designing effective treatment regimens against multidrug resistant Gram-negative pathogens;International Journal of Antimicrobial Agents;2024-04